Sandra Jesse, VP & CLO at HAEMONETICS CORP (HAE), bought 285 shares at $61.46 ($18K) on 2012-11-01, disclosed to the SEC on 2012-11-05.
Open-market purchase of $18k HAE by VP & CLO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| HAE | BUY | 2013-05-02 | $20K | — | Filing → |
| HAE | BUY | 2012-05-03 | $25K | — | Filing → |